DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B

被引:15
|
作者
Yousefelahiyeh, Mina [1 ]
Xu, Jingyi [1 ]
Alvarado, Estibaliz [1 ]
Yu, Yang [1 ]
Salven, David [1 ]
Nissen, Robert M. [1 ]
机构
[1] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA
来源
PLOS ONE | 2018年 / 13卷 / 11期
关键词
PROTEIN-KINASE DYRK1A; DOWN-SYNDROME; AURICULOCONDYLAR SYNDROME; SUBCELLULAR-LOCALIZATION; HUMAN PAPILLOMAVIRUSES; E6; PROTEINS; GENE; MINIBRAIN; E1A; ACTIVATION;
D O I
10.1371/journal.pone.0207779
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Overexpression of the Dual-specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) gene contributes to the retardation, craniofacial anomalies, cognitive impairment, and learning and memory deficits associated with Down Syndrome (DS). DCAF7/HAN11/WDR68 (hereafter WDR68) binds DYRK1A and is required for craniofacial development. Accumulating evidence suggests DYRK1A-WDR68 complexes enable proper growth and patterning of multiple organ systems and suppress inappropriate cell growth/transformation by regulating the balance between proliferation and differentiation in multiple cellular contexts. Here we report, using engineered mouse C2C12 and human HeLa cell lines, that WDR68 is required for normal levels of DYRK1A. However, Wdr68 does not significantly regulate Dyrk1a mRNA expression levels and proteasome inhibition did not restore DYRK1A in cells lacking Wdr68 (Delta wdr68 cells). Overexpression of WDR68 increased DYRK1A levels while overexpression of DYRK1A had no effect on WDR68 levels. We further report that WDR68 is similarly required for normal levels of the closely related DYRK1B kinase and that both DYRK1A and DYRK1B are essential for the transition from proliferation to differentiation in C2C12 cells. These findings reveal an additional role of WDR68 in DYRK1A-WDR68 and DYRK1B-WDR68 complexes.
引用
收藏
页数:23
相关论文
共 50 条
  • [41] Serine/threonine kinase Mirk/Dyrk1B mediates survival in rhabdomyosarcomas
    Shah, SS
    Mercer, SE
    Ewton, DZ
    Naqvi, A
    Friedman, E
    LABORATORY INVESTIGATION, 2006, 86 : 18A - 18A
  • [42] Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis
    Chen, Yingying
    Wang, Shuo
    He, Zhixian
    Sun, Fulan
    Huang, Yeqing
    Ni, Qichao
    Wang, Hua
    Wang, Yingying
    Cheng, Chun
    HUMAN PATHOLOGY, 2017, 66 : 48 - 58
  • [43] Serine/threonine kinase Mirk/Dyrk1B mediates survival in rhabdomyosarcomas
    Shah, SS
    Mercer, SE
    Ewton, DZ
    Naqvi, A
    Friedman, E
    MODERN PATHOLOGY, 2006, 19 : 18A - 18A
  • [44] DCAF7 is required for maintaining the cellular levels of ERCC1-XPF and nucleotide excision repair
    Kawara, Hiroaki
    Akahori, Ryo
    Wakasugi, Mitsuo
    Sancar, Aziz
    Matsunaga, Tsukasa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 519 (01) : 204 - 210
  • [45] The Molecular Chaperone TRiC/CCT Binds to the Trp-Asp 40 (WD40) Repeat Protein WDR68 and Promotes Its Folding, Protein Kinase DYRK1A Binding, and Nuclear Accumulation
    Miyata, Yoshihiko
    Shibata, Takeshi
    Aoshima, Masato
    Tsubata, Takuichi
    Nishida, Eisuke
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (48) : 33320 - 33332
  • [46] DYRK1A Is a Therapeutic Target in B-ALL in Children with Down Syndrome
    Lee, Paul
    Bhansali, Rahul
    Rammohan, Malini
    Hijiya, Nobuko
    Izraeli, Shai
    Bourquin, Jean-Pierre
    Malinge, Sebastien
    Crispino, John
    BLOOD, 2016, 128 (22)
  • [47] The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma
    Deng, Xiaobing
    Ewton, Daina Z.
    Li, Sheena
    Naqvi, Asghar
    Friedman, Eileen
    CANCER RESEARCH, 2006, 66 (08) : 4149 - 4158
  • [48] How to design potent and selective DYRK1B inhibitors? Molecular modeling study
    Szamborska-Gbur, Agnieszka
    Rutkowska, Ewelina
    Dreas, Agnieszka
    Frid, Michael
    Vilenchik, Maria
    Milik, Mariusz
    Brzozka, Krzysztof
    Krol, Marcin
    JOURNAL OF MOLECULAR MODELING, 2019, 25 (02)
  • [49] Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells
    Ewton, Daina Z.
    Hu, Jing
    Vilenchik, Maria
    Deng, Xiaobing
    Luk, Kin-chun
    Polonskaia, Ann
    Hoffman, Ann F.
    Zipf, Karen
    Boylan, John F.
    Friedman, Eileen A.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (11) : 2104 - 2114
  • [50] Harmine suppresses collagen production in hepatic stellate cells by inhibiting DYRK1B
    Yamaguchi, Momoka
    Ohbayashi, Saya
    Ooka, Akira
    Yamashita, Hinako
    Motohashi, Nanami
    Kaneko, Yukiko K.
    Kimura, Toshihide
    Saito, Shin-ya
    Ishikawa, Tomohisa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 600 : 136 - 141